The Smaller the Better – Compound Management Goes ‘Nano’

Posted: 04/11/2011
To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.
Join

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

Bill Skinner and Toby Winchester, Senior Principal Scientists at Pfizer, join Pharma IQ, to discuss the clean up of the Pfizer compound file.

In this exclusive interview, Bill reflects on developments from a data management perspective, while Toby reports on the logistical operations. They discuss the trend towards more compact files and explain what this means for Pfizer. They also discuss implementing the automatic release of compounds for screening – what it entails and what it means to overall store to screen process. Winchester explains what it means to go ‘Nano’ in terms of the overall dispensing, screening and/or drug discovery process, and comments on the technologies he expects will shape the future of compound management in the next 2-3 years.

The interview concludes with a discussion on how biologics and chemists can work together to achieve better results, and Skinner and Winchester offer some teamwork tips for the smooth running of a compound management facility.

  Have Your Say
Rate this feature and give us your feedback in the comments section below

Contributor: